Anixa Biosciences
ANIX
ANIX
32 hedge funds and large institutions have $11.5M invested in Anixa Biosciences in 2021 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 10 increasing their positions, 4 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
1.86% more ownership
Funds ownership: 8% → 9.86% (+1.9%)
3% less capital invested
Capital invested by funds: $11.8M → $11.5M (-$303K)
Holders
32
Holding in Top 10
–
Calls
$118K
Puts
$59K
Top Buyers
| 1 | +$483K | |
| 2 | +$387K | |
| 3 | +$204K | |
| 4 |
Morgan Stanley
New York
|
+$186K |
| 5 |
Two Sigma Advisers
New York
|
+$186K |
Top Sellers
| 1 | -$122K | |
| 2 | -$94K | |
| 3 | -$92K | |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$62K |
| 5 |
DWA
Dorsey Wright & Associates
Pasadena,
California
|
-$37.9K |